🇺🇸 FDA
Patent

US 10874745

Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs

granted A61KA61K38/00A61K47/62

Quick answer

US patent 10874745 (Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K47/62, A61K47/6811, A61P